
We discover and develop novel therapeutics for patients living with inflammatory and autoimmune conditions. $PTN
Cranbury, NJ
Joined February 2013
- Tweets152
- Following118
- Followers895
- Likes31
🚨 Breaking News 🚨: FDA confirms the acceptability of Palatin's Phase 3 trials for PL9643 in Dry Eye Disease! 🌟 Strong tolerability & safety profile. A major step forward in eye care innovation. Learn more: tinyurl.com/PalatinTech
#DryEyeDisease #ClinicalTrials #Biotech
2
7
1,095
💡 Rapid & effective symptom relief for Dry Eye Disease is on the horizon! PL9643 is advancing through Phase 3 trials, bringing us closer to a new therapeutic option. Stay informed: tinyurl.com/PalatinTech
#EyeCare #Innovation #PalatinTech #DED
1
1,008
🚀 Palatin Technologies kicks off a Phase 2 obesity study w/ Bremelanotide & Tirzepatide. Learn more: palatin.com/press_releases/f…
1
2
863
This study aims to advance obesity treatment by combining our MCR4 agonists with incretin therapeutics. #ObesityTreatment #ClinicalTrials #Biotech #HealthcareInnovation
1
765
🔥 Breaking: Palatin Technologies $PTN reveals positive results from our Phase 3 trial of PL9643 for Dry Eye Disease at ASCRS 2024! 🌐 Quick relief & excellent safety. Dive into the future of eye care with us! 🚀 #EyeHealth #Biotech palatin.com/press_releases/p…
766
$PTN Vyleesi® (bremelanotide injection) delivers its 7th consecutive quarter of double-digit growth in product revenue and prescriptions dispensed. Prescriptions grew 18% & net product revenue increased 14% over the prior quarter. bit.ly/3ScqRe9
1,232















